Table 4_BKI-1748: Efficacy Data for Congenital Toxoplasmosis Treatment in Sheep

A 123.7 KB document from a 2026 study by Roberto Sánchez-Sánchez on figshare. It details the results of a treatment trial for congenital toxoplasmosis in pregnant sheep, where the compound BKI-1748 was administered after IgM seroconversion. The study reports lamb viability and infection rates for treated versus untreated groups.

Use Cases

• Analyzing treatment efficacy based on lamb viability rates reported in the study
• Comparing IgG seroconversion timelines between treated and untreated groups as described
• Evaluating prenatal treatment strategies for congenital infections based on the described sheep model

Strengths

• Specific efficacy metrics are provided, such as 91% lamb viability in treated animals versus 52% in untreated
• The study design details are explicitly described, including a 10-dose oral treatment regimen at 15 mg/kg
• Data is shared under a permissive CC-BY-4.0 license

Limitations

• The dataset is a 123.7 KB DOCX file, indicating a very small and likely summary-level document rather than raw experimental data
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment for quantitative analysis

Provenance

Source

figshare

Collection Method

Likely contains summarized results from a controlled animal trial, as described.

Freshness

Last updated 2026-04-27 05:18:19